Search Results - "Piironen, T."

Refine Results
  1. 1

    Soluble urokinase plasminogen activator receptor as a prognostic marker in men participating in prostate cancer screening by Kjellman, A., Akre, O., Gustafsson, O., Høyer‐Hansen, G., Lilja, H., Norming, U., Piironen, T., Törnblom, M.

    Published in Journal of internal medicine (01-03-2011)
    “…  Kjellman A, Akre O, Gustafsson O, Høyer‐Hansen G, Lilja H, Norming U, Piironen T, Törnblom M (Department of Clinical Science, Intervention, and Technology;…”
    Get full text
    Journal Article
  2. 2

    Production and Characterization of Novel Anti-Prostate-specific Antigen (PSA) Monoclonal Antibodies That Do Not Detect Internally Cleaved Lys145-Lys146 Inactive PSA by Nurmikko, Pauliina, Vaisanen, Ville, Piironen, Timo, Lindgren, Sari, Lilja, Hans, Pettersson, Kim

    Published in Clinical chemistry (Baltimore, Md.) (01-10-2000)
    “…The nature of free, uncomplexed prostate-specific antigen (PSA) in the circulation is still unknown. In this study, we developed novel anti-PSA antibodies…”
    Get full text
    Journal Article
  3. 3

    Reduced Release of Intact and Cleaved Urokinase Receptor in Stimulated Whole‐Blood Cultures from Human Immunodeficiency Virus‐1‐Infected Patients by Ostrowski, S. R., Piironen, T., Høyer‐Hansen, G., Gerstoft, J., Pedersen, B. K., Ullum, H.

    Published in Scandinavian journal of immunology (01-04-2005)
    “…The blood levels of the soluble forms of the urokinase receptor (suPAR) are increased in human immunodeficiency virus (HIV)‐1‐infected patients. This study…”
    Get full text
    Journal Article
  4. 4

    The importance of human glandular kallikrein and its correlation with different prostate specific antigen serum forms in the detection of prostate carcinoma by Recker, Franz, Kwiatkowski, Maciej K., Piironen, Timo, Pettersson, Kim, Lümmen, Gerd, Wernli, Martin, Wiefelspütz, Johannes, Graber, Samuel F., Goepel, Mark, Huber, Andreas, Tscholl, Reto

    Published in Cancer (15-12-1998)
    “…BACKGROUND Human glandular kallikrein (hK2), the prostate specific antigen (PSA) close homologue, possesses approximately 80% structure identity with PSA. The…”
    Get full text
    Journal Article
  5. 5

    Characterization and processing of prostate specific antigen (hK3) and human glandular kallikrein (hK2) secreted by LNCaP cells by Väisänen, V, Lövgren, J, Hellman, J, Piironen, T, Lilja, H, Pettersson, K

    Published in Prostate cancer and prostatic diseases (01-03-1999)
    “…Prostate specific antigen (PSA, hK3) in serum is predominantly complexed to alpha-1-antichymotrypsin (ACT), but a minor fraction remains in a free form despite…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Measurement of Circulating Forms of Prostate-specific Antigen in Whole Blood Immediately after Venipuncture: Implications for Point-of-Care Testing by Piironen, Timo, Nurmi, Martti, Irjala, Kerttu, Heinonen, Olli, Lilja, Hans, Lovgren, Timo, Pettersson, Kim

    Published in Clinical chemistry (Baltimore, Md.) (01-04-2001)
    “…The purpose of this study was to validate the use of whole-blood samples in the determination of circulating forms of prostate-specific antigen (PSA). Blood…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Enhanced expression of prostate-specific antigen in the transition zone of the prostate. A characterization following prostatectomy for benign hyperplasia by Recker, F, Kwiatkowski, M K, Pettersson, K, Piironen, T, Lümmen, G, Huber, A, Tscholl, R

    Published in European urology (1998)
    “…To determine whether the serum levels of total prostate-specific antigen (t-PSA), free PSA (f-PSA) and PSA complexed to alpha 1-antichymotrypsin (PSA-ACT)…”
    Get more information
    Journal Article
  11. 11

    Epitope mapping of human prostate specific antigen and glandular kallikrein expressed in insect cells by Rajakoski, K, Piironen, T, Pettersson, K, Lövgren, J, Karp, M

    Published in Prostate cancer and prostatic diseases (01-09-1997)
    “…Two human prostate gland proteases were expressed in insect cells using recombinant baculovirus expression system. Prostate specific antigen (PSA) is an…”
    Get full text
    Journal Article
  12. 12

    Free‐to‐total prostate‐specific antigen (PSA) ratio improves the specificity for detecting prostate cancer in patients with prostatism and intermediate PSA levels by RECKER, F, KWIATKOWSKI, M. K, PIIRONEN, T, PETTERSSON, K, GOEPEL, M, TSCHOLL, R

    Published in British Journal of Urology (01-04-1998)
    “…Objective  To investigate the clinical significance of the free‐to‐total prostate‐specific antigen (PSA) ratio in improving the specificity of PSA measurement…”
    Get full text
    Journal Article
  13. 13

    Reactivity of anti-PSA monoclonal antibodies with recombinant human kallikrein-2 by Leinonen, J, Leinimaa, M, Zhang, W M, Piironen, T, Pettersson, K, Lilja, H, Dowell, B, Stenman, U H

    Published in Tumor biology (1999)
    “…Seventy-nine monoclonal antibodies submitted to the ISOBM TD-3 PSA Workshop were tested for their reactivity with recombinant human kallikrein-2 (rhK2). A…”
    Get more information
    Journal Article
  14. 14

    Reproducibility and accuracy of measurements of free and total prostate-specific antigen in serum vs plasma after long-term storage at -20 degrees C by Ulmert, David, Becker, Charlotte, Nilsson, Jan-Ake, Piironen, Timo, Björk, Thomas, Hugosson, Jonas, Berglund, Göran, Lilja, Hans

    Published in Clinical chemistry (Baltimore, Md.) (01-02-2006)
    “…Long-term frozen storage may alter the results of prostate-specific antigen (PSA) measurements, mainly because of degradation of free PSA (fPSA) in vitro. We…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Specific Immunoassays for Detection of Intact and Cleaved Forms of the Urokinase Receptor by Piironen, Timo, Laursen, Birgitte, Pass, Jesper, List, Karin, Gardsvoll, Henrik, Ploug, Michael, Dano, Keld, Hoyer-Hansen, Gunilla

    Published in Clinical chemistry (Baltimore, Md.) (01-11-2004)
    “…The cell surface receptor (uPAR) for urokinase plasminogen activator (uPA) is a strong prognostic marker in several types of cancer. uPA cleaves the…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    Clinical value of human glandular kallikrein 2 and free and total prostate-specific antigen in serum from a population of men with prostate-specific antigen levels 3.0 ng/mL or greater by Becker, Charlotte, Piironen, Timo, Pettersson, Kim, Hugosson, Jonas, Lilja, Hans

    Published in Urology (Ridgewood, N.J.) (01-05-2000)
    “…Objectives. To investigate the clinical value of human glandular kallikrein 2 (hK2) compared with free (f) and total (t) prostate-specific antigen (PSA) in the…”
    Get full text
    Journal Article
  20. 20

    Human glandular kallikrein 2 levels in serum for discrimination of pathologically organ-confined from locally-advanced prostate cancer in total PSA-levels below 10 ng/ml by Haese, Alexander, Graefen, Markus, Steuber, Thomas, Becker, Charlotte, Pettersson, Kim, Piironen, Timo, Noldus, Joachim, Huland, Hartwig, Lilja, Hans

    Published in The Prostate (01-10-2001)
    “…Background We measured serum levels of human glandular kallikrein 2 (hK2) in patients treated with radical retropubic prostatectomy (rrP) for clinically…”
    Get full text
    Journal Article